1. Home
  2. BIO vs MTZ Comparison

BIO vs MTZ Comparison

Compare BIO & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

SELL

Current Price

$361.70

Market Cap

10.3B

Sector

Industrials

ML Signal

SELL

Logo MasTec Inc.

MTZ

MasTec Inc.

SELL

Current Price

$179.20

Market Cap

15.9B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
BIO
MTZ
Founded
1952
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Water Sewer Pipeline Comm & Power Line Construction
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
15.9B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
BIO
MTZ
Price
$361.70
$179.20
Analyst Decision
Hold
Strong Buy
Analyst Count
3
21
Target Price
★ $356.67
$313.67
AVG Volume (30 Days)
232.9K
★ 1.8M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
142.61
★ 146.12
EPS
★ 11.25
4.32
Revenue
$2,583,200,000.00
★ $14,299,171,000.00
Revenue This Year
N/A
$27.87
Revenue Next Year
$1.86
$17.61
P/E Ratio
★ $32.60
$42.33
Revenue Growth
0.65
★ 16.22
52 Week Low
$236.73
$147.49
52 Week High
$396.23
$441.43

Technical Indicators

Market Signals
Indicator
BIO
MTZ
Relative Strength Index (RSI) 43.18 45.11
Support Level $354.27 $164.31
Resistance Level $392.10 $203.46
Average True Range (ATR) 12.87 12.58
MACD -1.34 2.14
Stochastic Oscillator 23.83 57.01

Price Performance

Historical Comparison
BIO
MTZ

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.

Share on Social Networks: